HSK7653

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for HSK7653, covering 2022-12-12 to 2024-11-25. Get the full timeline:

Most recent: Clinical Trial Update: HSK7653 in Chinese Patients with Impaired Glucose Tolerance [Phase 2]